Shigeta Hiroaki 4

4 · MEDICINES CO /DE · Filed Mar 28, 2013

Form 4

Period: 2013-03-26

Director

Transactions

Exercise/Conversion
Common Stock
2013-03-26$19.60/sh+7,500$147,000→ 26,000 total
Sale
Common Stock
2013-03-26$33.50/sh−7,500$251,250→ 18,500 total
Exercise/Conversion
Options (Right to buy)
2013-03-26−18,259→ 0 total
Exercise: $18.18Exp: 2021-05-26→ Common Stock (18,259 underlying)
Exercise/Conversion
Common Stock
2013-03-26$18.18/sh+18,259$331,949→ 36,759 total
Sale
Common Stock
2013-03-26$33.50/sh−7,500$251,250→ 18,500 total
Exercise/Conversion
Options (Right to buy)
2013-03-26−7,500→ 0 total
Exercise: $19.60Exp: 2017-05-24→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2013-03-26$18.30/sh+7,500$137,250→ 26,000 total
Sale
Common Stock
2013-03-26$33.50/sh−18,259$611,677→ 18,500 total
Exercise/Conversion
Options (Right to buy)
2013-03-26−7,500→ 0 total
Exercise: $18.30Exp: 2018-05-29→ Common Stock (7,500 underlying)

Footnotes (4)

[F1]The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Shigeta on February 22, 2013.
[F2]As of 3/26/2013, the original grant (7,500 shares granted on 5/24/2007) was fully vested.
[F3]As of 3/26/2013, the original grant (7,500 shares granted on 5/29/2008) was fully vested.
[F4]As of 3/26/2013, the original grant (18,259 shares granted on 5/26/2011) was fully vested.

Documents

1 file